Skip to main content

$0.125 (0%)

High

$0.13

Low

$0.12

Trades

20

Turnover

$48,049

Volume

400,697
30 June 2023 at 3:57pm
Register to track CYP and receive email alerts.
Subject
CYP Ann: Notification regarding unquoted securities - CYP

CYP Ann: Proposed issue of securities - CYP

CYP Ann: Cynata announces CEO succession and Board changes

CYP Ann: Change in substantial holding

CYP Ann: Appendix 3Ys x 6

CYP Ann: Top 20 Listed Optionholders & Distribution Schedule

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Cleansing Notice

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Results of Meeting

CYP Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Cynata Completes Oversubscribed Share Purchase Plan

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Proposed issue of securities - CYP

CYP Ann: Letter to Shareholders, Notice of Meeting & Proxy Form

CYP Ann: Cleansing Notice

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Target Market Determination

CYP Ann: Share Purchase Plan Booklet & Option Prospectus

CYP Ann: Cleansing Notice

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Ethics Committee Approval for Proposed aGvHD Phase 2 Trial

CYP Ann: Capital Raising Presentation

CYP Ann: Proposed issue of securities - CYP

CYP Ann: Cynata completes $5.0m Placement and launches SPP

CYP Ann: Trading Halt

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: Cynata Adds New Sites for DFU Clinical Trial

CYP Ann: Appendix 4D & Half-Year Financial Statements

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Receives IRB Approval for aGvHD Clinical Trial

CYP Ann: Notice of Acceptance for Cynata Australian Patent

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: Cynata Receives $1.65m R&D Tax Incentive Refund

CYP Ann: Appendix 3Y - Janine Rolfe

CYP Ann: Notification regarding unquoted securities - CYP

CYP Ann: Results of AGM

CYP Ann: AGM Presentations

CYP Ann: Conference Data Demonstrating Consistency of Cynata MSCs

CYP Ann: Notice of Allowance for Cynata US Patent

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: New Kidney Transplantation Clinical Trial for Cynata & LUMC

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Annual Report to Shareholders

CYP Ann: Letter to Shareholders, Notice of AGM & Proxy Form

CYP Ann: Notice of Allowance for Australia & Canada Cymerus Patents

CYP Ann: Successful Completion of Planned DSMB Review of DFU Trial

CYP Ann: Date of AGM and Closing Date for Director Nominations

Register to track CYP and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX